From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society

Robert J. Volk; Viola B. Leal; Lianne E. Jacobs; Andrew M.D. Wolf; Durado D. Brooks; Richard C. Wender; Robert A. Smith

doi:10.3322/caac.21459

From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society

Robert J. Volk, Viola B. Leal, Lianne E. Jacobs, Andrew M.D. Wolf, Durado D. Brooks, Richard C. Wender, Robert A. Smith

Health Services Research

Research output: Contribution to journal › Comment/debate › peer-review

28 Scopus citations

Original language	English (US)
Pages (from-to)	246-249
Number of pages	4
Journal	CA Cancer Journal for Clinicians
Volume	68
Issue number	4
DOIs	https://doi.org/10.3322/caac.21459
State	Published - Jul 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.3322/caac.21459

Cite this

@article{0a87b5b6103d4b348a296bfc318eace3,

title = "From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society",

author = "Volk, {Robert J.} and Leal, {Viola B.} and Jacobs, {Lianne E.} and Wolf, {Andrew M.D.} and Brooks, {Durado D.} and Wender, {Richard C.} and Smith, {Robert A.}",

note = "Funding Information: Department of Health Services Research, Unit 1444, The University of Texas MD Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402; bvolk@mdanderson.org Disclosures: The American Cancer Society (ACS) receives partial funding from the Centers for Disease Control and Prevention to support the National Colorectal Cancer Roundtable, of which Richard C. Wender is the Chair, Robert A. Smith is the Co-Chair, and Durado D. Brooks is a Steering Committee member, to support initiatives related to colorectal cancer screening. The ACS also received contributions from Bracco Diagnostics Inc, Polymedco Inc, Exact Sciences, Medtronic GI Solutions Inc, Quest Diagnostics, Epigenomics Inc, Clinical Genomics, Medial EarlySign, the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology, the American College of Radiology, and the American Gastroenterological Association to support the annual meeting of the National Colorectal Cancer Roundtable. ACS cancer screening guideline development is supported by ACS operational funds; neither the Roundta-bles nor sources of funding described in this disclosure have had any role, involvement, or have made any financial contribution to ACS screening guideline development or approval. This work was also supported in part by a grant to Robert J. Volk from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment. The decision support tools described in this commentary were developed under a contract between The University of Texas MD Anderson Cancer Center and the ACS.",

year = "2018",

month = jul,

day = "1",

doi = "10.3322/caac.21459",

language = "English (US)",

volume = "68",

pages = "246--249",

journal = "CA Cancer Journal for Clinicians",

issn = "0007-9235",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - From guideline to practice

T2 - New shared decision-making tools for colorectal cancer screening from the American Cancer Society

AU - Volk, Robert J.

AU - Leal, Viola B.

AU - Jacobs, Lianne E.

AU - Wolf, Andrew M.D.

AU - Brooks, Durado D.

AU - Wender, Richard C.

AU - Smith, Robert A.

N1 - Funding Information: Department of Health Services Research, Unit 1444, The University of Texas MD Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402; bvolk@mdanderson.org Disclosures: The American Cancer Society (ACS) receives partial funding from the Centers for Disease Control and Prevention to support the National Colorectal Cancer Roundtable, of which Richard C. Wender is the Chair, Robert A. Smith is the Co-Chair, and Durado D. Brooks is a Steering Committee member, to support initiatives related to colorectal cancer screening. The ACS also received contributions from Bracco Diagnostics Inc, Polymedco Inc, Exact Sciences, Medtronic GI Solutions Inc, Quest Diagnostics, Epigenomics Inc, Clinical Genomics, Medial EarlySign, the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology, the American College of Radiology, and the American Gastroenterological Association to support the annual meeting of the National Colorectal Cancer Roundtable. ACS cancer screening guideline development is supported by ACS operational funds; neither the Roundta-bles nor sources of funding described in this disclosure have had any role, involvement, or have made any financial contribution to ACS screening guideline development or approval. This work was also supported in part by a grant to Robert J. Volk from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment. The decision support tools described in this commentary were developed under a contract between The University of Texas MD Anderson Cancer Center and the ACS.

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85047744065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047744065&partnerID=8YFLogxK

U2 - 10.3322/caac.21459

DO - 10.3322/caac.21459

M3 - Comment/debate

C2 - 29846954

AN - SCOPUS:85047744065

SN - 0007-9235

VL - 68

SP - 246

EP - 249

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

IS - 4

ER -

From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this